We are live on ! Find out more
ATOS icon

Atossa Therapeutics

52 hedge funds and large institutions have $20.2M invested in Atossa Therapeutics in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,419% more call options, than puts

Call options by funds: $1.38M | Put options by funds: $91K

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

70% more capital invested

Capital invested by funds: $11.9M → $20.2M (+$8.32M)

16% more funds holding

Funds holding: 4552 (+7)

0.02% less ownership

Funds ownership: 0.86%0.84% (-0.02%)

29% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 14

Holders
52
Holders Change
+7
Holders Change %
+15.56%
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
10
Reduced
14
Closed
3
Calls
$1.38M
Puts
$91K
Net Calls
+$1.29M
Net Calls Change
+$576K
Name Holding Trade Value Shares
Change
Change in
Stake
LNC
51
Lincoln National Corp
Pennsylvania
-$7.5K -689 Closed
National Bank of Canada
52
National Bank of Canada
Quebec, Canada
-$1K -93 Closed
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
+$133 +11 +1,100%